<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02386020</url>
  </required_header>
  <id_info>
    <org_study_id>GDCRI/ACM/PG/PhD/10E/2013-14</org_study_id>
    <nct_id>NCT02386020</nct_id>
  </id_info>
  <brief_title>Aloe Vera in Chronic Periodontitis With Type 2 Diabetes Mellitus</brief_title>
  <official_title>Clinical Efficacy of Locally Delivered Aloe Vera Gel as an Adjunct to Non-surgical Periodontal Therapy in Chronic Periodontitis Subjects With Type 2 Diabetes Mellitus: a Randomized Controlled Clinical Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Government Dental College and Research Institute, Bangalore</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Government Dental College and Research Institute, Bangalore</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The present study is designed to investigate the effectiveness of AV gel local drug delivery&#xD;
      as an adjunct to scaling and root planing (SRP) in the treatment of subjects with chronic&#xD;
      periodontitis (CP) and type 2 diabetes mellitus (DM).&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      BACKGROUND: Advances in the field of alternative medicine have promoted widespread use of&#xD;
      herbal agents, like Aloe vera (AV), for both medical and dental therapy. AV has&#xD;
      anti-inflammatory, antioxidant, antimicrobial, hypoglycaemic, healing promoting and immune&#xD;
      boosting properties. The present study is designed to investigate the effectiveness of AV gel&#xD;
      local drug delivery as an adjunct to scaling and root planing (SRP) in the treatment of&#xD;
      subjects with chronic periodontitis (CP) and type 2 diabetes mellitus (DM).&#xD;
&#xD;
      MATERIAL AND METHODS: A total of 60 subjects with probing depth (PD) ≥5mm and clinical&#xD;
      attachment level (CAL) ≥3mm were randomly divided into two groups. Group 1 was treated with&#xD;
      SRP + placebo gel local drug delivery (LDD) and Group 2 with SRP + AV gel LDD. Clinical&#xD;
      parameters including full mouth plaque index (PI), modiﬁed sulcus bleeding index (mSBI),&#xD;
      probing depth (PD) and clinical attachment level (CAL) were recorded first at baseline and&#xD;
      then at intervals of 3 months and 6 months.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>June 2014</start_date>
  <completion_date type="Actual">December 2014</completion_date>
  <primary_completion_date type="Actual">December 2014</primary_completion_date>
  <phase>Phase 2/Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in Clinical attachment level</measure>
    <time_frame>baseline to 6 months</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change in Plaque index</measure>
    <time_frame>baseline to 6 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in modified sulcus bleeding index</measure>
    <time_frame>baseline to 6 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Probing depth</measure>
    <time_frame>baseline to 6 months</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">60</enrollment>
  <condition>Chronic Periodontitis</condition>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>After SRP, placebo gel was delivered subgingivally into periodontal pockets.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Aloe vera</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>After SRP, aloe vera gel was delivered subgingivally into periodontal pockets.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>aloe vera</intervention_name>
    <description>After SRP, aloe vera gel was delivered subgingivally into periodontal pockets.</description>
    <arm_group_label>Aloe vera</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>placebo gel</intervention_name>
    <description>After SRP, placebo gel was delivered subgingivally into periodontal pockets.</description>
    <arm_group_label>Placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Well-controlled type 2 DM&#xD;
&#xD;
          -  Chronic periodontitis with moderate to deep pockets [probing depth (PD) ≥5mm and&#xD;
             clinical attachment loss (CAL) ≥3mm]&#xD;
&#xD;
          -  No history of antibiotic or periodontal therapy in the preceding 6 months.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Any known disease/condition or on any medication that can affect the periodontal&#xD;
             status&#xD;
&#xD;
          -  Known or suspected allergy to herbal medications&#xD;
&#xD;
          -  Systemic antimicrobial therapy&#xD;
&#xD;
          -  Aggressive periodontitis&#xD;
&#xD;
          -  Smokers&#xD;
&#xD;
          -  Alcoholics&#xD;
&#xD;
          -  Immunocompromised patients&#xD;
&#xD;
          -  Pregnant or lactating females&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>25 Years</minimum_age>
    <maximum_age>45 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <verification_date>February 2015</verification_date>
  <study_first_submitted>February 18, 2015</study_first_submitted>
  <study_first_submitted_qc>March 5, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 11, 2015</study_first_posted>
  <last_update_submitted>March 5, 2015</last_update_submitted>
  <last_update_submitted_qc>March 5, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">March 11, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Government Dental College and Research Institute, Bangalore</investigator_affiliation>
    <investigator_full_name>Dr. A R Pradeep</investigator_full_name>
    <investigator_title>Professor &amp; Head, Department of Periodontology</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Periodontitis</mesh_term>
    <mesh_term>Chronic Periodontitis</mesh_term>
    <mesh_term>Diabetes Mellitus</mesh_term>
    <mesh_term>Diabetes Mellitus, Type 2</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

